Skip to main content
Clinical Trials/CTRI/2020/11/028968
CTRI/2020/11/028968
Not Yet Recruiting
N/A

Establish serial sero-surveillance to monitor the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the general population. - Sero-survey

ational Biopharma Mission NBM Biotechnology Industry Research Assistance Council BIRAC0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: A90- Dengue fever [classical dengue]Health Condition 3: B978- Other viral agents as the cause ofdiseases classified elsewhere
Sponsor
ational Biopharma Mission NBM Biotechnology Industry Research Assistance Council BIRAC
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
ational Biopharma Mission NBM Biotechnology Industry Research Assistance Council BIRAC

Eligibility Criteria

Inclusion Criteria

  • Survey will be carried out in individuals above 2 years of age and all individuals currently residing and likely to stay till the end of study (1 year) in the study area will be considered eligible for inclusion.

Exclusion Criteria

  • Consent refusal

Outcomes

Primary Outcomes

Not specified

Similar Trials